Bioventus (BVS) EBITDA Margin Growth (3y) (2023 - 2026)
Powered by 
Analysis
Bioventus (BVS) EBITDA Margin Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -201.00 |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 722.00 |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 162.00 |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 586.00 |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 736.00 |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 887.00 |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -1,075.00 |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 963.00 |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 244.00 |
| 10 | Bioventus | 1.18 Bn | 1.20 Bn | 105.67 Mn | 756.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 756.00 |
| Mar 28, 2026 | 8,369.00 |
| Dec 31, 2025 | 2,477.00 |
| Sep 27, 2025 | 10,670.00 |
| Jun 28, 2025 | 1,480.00 |
| Mar 29, 2025 | 2,222.00 |
| Dec 31, 2024 | 743.00 |
| Sep 28, 2024 | 359.00 |
| Jun 29, 2024 | -1,559.00 |
| Mar 30, 2024 | -2,309.00 |
| Dec 31, 2023 | -513.00 |
| Sep 30, 2023 | -607.00 |
| Jul 1, 2023 | 1,284.00 |
| Apr 1, 2023 | -9,384.00 |